This site is intended for Healthcare professionals only.

Sun Pharma, Moebius Medical ink pact to develop pain product


Sun Pharma, Moebius Medical ink pact to develop pain product

Sun Pharmaceutical Industries and Israel-based Moebius Medical have signed a global licensing pact to develop further an injection for treating osteoarthritis pain.

The exclusive worldwide licensing deal is to further develop MM-II, a novel non-opioid pain product for osteoarthritis, the companies said in a joint statement.



Source: PTI
0 comment(s) on Sun Pharma, Moebius Medical ink pact to develop pain product

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted